Orbis Medicines is thrilled to announce that we have successfully raised $97 million in our latest funding round, marking a significant milestone in our journey to revolutionize the drug discovery landscape. Our innovative platform is at the forefront of addressing some of the most challenging targets in pharmaceutical development, and this infusion of capital will accelerate our mission to discover, develop, and deliver novel drug candidates that can transform patient outcomes. With this funding, we plan to expand our research capabilities and enhance our technological infrastructure, enabling us to streamline the drug discovery process and increase the speed at which we can bring effective therapies to market. The new investment will also support our efforts to recruit top-tier talent, further strengthening our team of experts who are dedicated to pushing the boundaries of what’s possible in the pharmaceutical industry. As we move forward, we remain committed to harnessing our cutting-edge platform to not only tackle current medical challenges but also to pave the way for future innovations in drug development. We are grateful to our investors for their confidence in our vision and capabilities, and we are excited to see what the future holds as we work diligently to transform scientific breakthroughs into viable therapeutic options for patients in need. Stay tuned for updates as we continue to make strides toward advancing healthcare and improving lives around the world.
Orbis Medicines Secures $97 Million in Series A Funding to Pioneer Drug Discovery Platform
Recently funded · $97.0M Series aChemicals/Pharmaceuticals
Get the full Orbis Medicines company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
